3-[3-[(4-cyanophenyl)carbamoylamino]-4-(3,5-dimethylpiperidin-1-yl)phenyl]-4,4,4-trifluorobutanoic acid
C25H27F3N4O3 — CID 156782468
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3-[(4-cyanophenyl)carbamoylamino]-4-(3,5-dimethylpiperidin-1-yl)phenyl]-4,4,4-trifluorobutanoic acid
3-[3-[(4-cyanophenyl)carbamoylamino]-4-(3,5-dimethylpiperidin-1-yl)phenyl]-4,4,4-trifluorobutanoic acid (PubChem CID 156782468) has the molecular formula C25H27F3N4O3 and a molecular weight of 488.51 g/mol. Its IUPAC name is 3-[3-[(4-cyanophenyl)carbamoylamino]-4-(3,5-dimethylpiperidin-1-yl)phenyl]-4,4,4-trifluorobutanoic acid.
Molecular Properties
| Compound Name | 3-[3-[(4-cyanophenyl)carbamoylamino]-4-(3,5-dimethylpiperidin-1-yl)phenyl]-4,4,4-trifluorobutanoic acid |
|---|---|
| PubChem CID | 156782468 |
| Molecular Formula | C25H27F3N4O3 |
| Molecular Weight | 488.51 g/mol |
| Exact Mass | 488.20 |
| IUPAC Name | 3-[3-[(4-cyanophenyl)carbamoylamino]-4-(3,5-dimethylpiperidin-1-yl)phenyl]-4,4,4-trifluorobutanoic acid |
| SMILES | CC1CC(C)CN(c2ccc(C(CC(=O)O)C(F)(F)F)cc2NC(=O)Nc2ccc(C#N)cc2)C1 |
| InChI | InChI=1S/C25H27F3N4O3/c1-15-9-16(2)14-32(13-15)22-8-5-18(20(11-23(33)34)25(26,27)28)10-21(22)31-24(35)30-19-6-3-17(12-29)4-7-19/h3-8,10,15-16,20H,9,11,13-14H2,1-2H3,(H,33,34)(H2,30,31,35) |
| InChIKey | RAPAUYVEJJSOQF-UHFFFAOYSA-N |
| XLogP | 5.81 |
| TPSA | 105.46 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 488.51 |
| LogP ≤ 5 | 5.81 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156782468 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.